Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baijun Fang

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Bioscience (Landmark Edition)|December 6, 2025
Epirubicin Induces Cell Cycle Arrest in Multiple Myeloma Cells by Downregulating CDC20 ExpressionZhen Nan, Xueting Wang, Yaomei Wang, et al.
American Journal of Hematology|November 11, 2011
Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemiaBaijun Fang, Yuzhang Liu, Jian Zhou, et al.
Cancer Management and Research|May 20, 2020
The Synchronous Presence of Multiple Myelomas and Other Primary Malignant Tumors: Case Series with Literature ReviewNing Li, Xiyang Liu, Yongping Song, et al.
The Journal of Laboratory and Clinical Medicine|April 16, 2004
Multipotency of Flk1CD34 progenitors derived from human fetal bone marrowBaijun Fang, Lianming Liao, Mingxia Shi, et al.
Case Reports in Oncology|April 26, 2011
Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on ImatinibBaijun Fang, Ling Mai, Ning Li, et al.
Acta Haematologica|May 22, 2008
Cotransplantation of haploidentical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemiaBaijun Fang, Yongping Song, Ning Li, et al.
American Journal of Hematology|June 19, 2007
Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cellsBaijun Fang, Yongping Song, Robert Chunhua Zhao, et al.
Annals of Hematology|May 26, 2010
Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinibBaijun Fang, Ning Li, Yongping Song, et al.
Biotechnology Letters|March 24, 2009
Comparison of human post-embryonic, multipotent stem cells derived from various tissuesBaijun Fang, Ning Li, Yongping Song, et al.
Translational Cancer Research|February 4, 2022
Preliminary study on the relationship among stem cell markers, drug resistance and PI3K signaling pathway in multiple myeloma (MM) cellNing Li, Bingshan Liu, Danyang Wang, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Bioscience (Landmark Edition)|December 6, 2025
Epirubicin Induces Cell Cycle Arrest in Multiple Myeloma Cells by Downregulating CDC20 ExpressionZhen Nan, Xueting Wang, Yaomei Wang, et al.
American Journal of Hematology|November 11, 2011
Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemiaBaijun Fang, Yuzhang Liu, Jian Zhou, et al.
Cancer Management and Research|May 20, 2020
The Synchronous Presence of Multiple Myelomas and Other Primary Malignant Tumors: Case Series with Literature ReviewNing Li, Xiyang Liu, Yongping Song, et al.
The Journal of Laboratory and Clinical Medicine|April 16, 2004
Multipotency of Flk1CD34 progenitors derived from human fetal bone marrowBaijun Fang, Lianming Liao, Mingxia Shi, et al.
Case Reports in Oncology|April 26, 2011
Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on ImatinibBaijun Fang, Ling Mai, Ning Li, et al.
Acta Haematologica|May 22, 2008
Cotransplantation of haploidentical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemiaBaijun Fang, Yongping Song, Ning Li, et al.
American Journal of Hematology|June 19, 2007
Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cellsBaijun Fang, Yongping Song, Robert Chunhua Zhao, et al.
Annals of Hematology|May 26, 2010
Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinibBaijun Fang, Ning Li, Yongping Song, et al.
Biotechnology Letters|March 24, 2009
Comparison of human post-embryonic, multipotent stem cells derived from various tissuesBaijun Fang, Ning Li, Yongping Song, et al.
Translational Cancer Research|February 4, 2022
Preliminary study on the relationship among stem cell markers, drug resistance and PI3K signaling pathway in multiple myeloma (MM) cellNing Li, Bingshan Liu, Danyang Wang, et al.
Pageof 9